Bioxyne Ltd has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-578
6ix hasn’t read this filing yet.
Earlier from Bioxyne
- Pause in Trading
- BXN H1 FY25 Results Presentation
- Quarterly Activities Report December 2024 Revised
- Revenue Guidance
- Addendum to Presentation dated 18 November 2024
Later from Bioxyne
- Bioxyne Raises A$3 million in Capital Raise
- BXN Signs Exclusive $7m Manufacturing and Supply Agreement
- FY25 Revenue Guidance Upgrade
- Certificate GMP Compliance EU, UK, Singapore & Canada
- Enters German Market Euro3.2m Manufacturing & Supply Agmt
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne